GANT61 plays antitumor effects by inducing oxidative stress through the miRNA‐1286/RAB31 axis in osteosarcoma

Kuai‐qiang Zhang,Xiang‐dong Chu
DOI: https://doi.org/10.1002/cbin.11467
IF: 4.473
2020-10-07
Cell Biology International
Abstract:<p>Osteosarcoma (OS) is a rare malignancy of bone associated with poor clinical outcomes. Anti‐tumor effects of GANT61 on OS is unclear. To investigate anti‐tumor effects and mechanism of GANT61 in OS cells and xeno‐graft model. Effects of GANT61 on cell viability, clone formation, cell cycle, apoptosis, migration and invasion ability of OS cells were assessed. Reactive oxygen species (ROS) levels measured by dichlorofluorescein fluorescence were used to evaluate oxidative stress. Xeno‐graft model was constructed to investigate anti‐tumor effects of GANT61 in vivo. miRNA‐1286 was down‐regulated, while RAB31 up‐regulated in OS tissues and cells. GANT61 inhibited viability, migration and invasion ability of OS cells (SaOS‐2 and U2OS), and induced apoptosis and the ROS production, along with miRNA‐1286 up‐regulation and RAB13 down‐regulation. After knockdown of miRNA‐1286, GANT6‐induced cell inhibition was attenuated, along with RAB31 up‐regulation. Inversely, miRNA‐1286 overexpression down‐regulated RAB31. Dual‐luciferase reporter assay verified that miR‐1286 negatively targeted RAB13. Moreover, the knock down of RAB31 stimulated apoptosis and ROS production while inhibited viability, migration and invasion of GANT61‐treated cells. In vivo experiments further confirmed that GANT61 inhibited tumor growth and RAB13 expression, but enhanced miRNA‐1286. The study demonstrated that GANT61 inhibited inhibited cell aggressive phenotype and tumor growth by inducing oxidative stress through miRNA‐1286/RAB31 axis. Our findings provided a potential anti‐tumor agent for the OS clinical treatment.</p><p>This article is protected by copyright. All rights reserved.</p>
cell biology
What problem does this paper attempt to address?